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Abstract
Brain serotonin (5-HT) is implicated in a wide range of functions from basic physiological mechanisms to complex behaviors,
including neuropsychiatric conditions, as well as in developmental processes. Increasing evidence links 5-HT signaling
alterations during development to emotional dysregulation and psychopathology in adult age. To further analyze the
importance of brain 5-HT in somatic and brain development and function, and more specifically differentiation and
specification of the serotonergic system itself, we generated a mouse model with brain-specific 5-HT deficiency resulting
from a genetically driven constitutive inactivation of neuronal tryptophan hydroxylase-2 (Tph2). Tph2 inactivation (Tph22/
2) resulted in brain 5-HT deficiency leading to growth retardation and persistent leanness, whereas a sex- and age-
dependent increase in body weight was observed in Tph2+/2 mice. The conserved expression pattern of the 5-HT neuron-
specific markers (except Tph2 and 5-HT) demonstrates that brain 5-HT synthesis is not a prerequisite for the proliferation,
differentiation and survival of raphe neurons subjected to the developmental program of serotonergic specification.
Furthermore, although these neurons are unable to synthesize 5-HT from the precursor tryptophan, they still display
electrophysiological properties characteristic of 5-HT neurons. Moreover, 5-HT deficiency induces an up-regulation of 5-HT1A
and 5-HT1B receptors across brain regions as well as a reduction of norepinephrine concentrations accompanied by a
reduced number of noradrenergic neurons. Together, our results characterize developmental, neurochemical,
neurobiological and electrophysiological consequences of brain-specific 5-HT deficiency, reveal a dual dose-dependent
role of 5-HT in body weight regulation and show that differentiation of serotonergic neuron phenotype is independent from
endogenous 5-HT synthesis.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT), a neuromodulator and
neurotransmitter extensively distributed in the brain, is involved in
the regulation of a wide range of basic physiological functions
including developmental processes, synaptic plasticity as well as
metabolic homeostasis, neuroendocrine function, appetite, energy
expenditure, respiratory rate or sleep. In addition, the 5-HT
system, also through its capacity to modulate the activity of other
neuronal networks, shapes and regulates cognition and complex
emotional behaviors including in interaction with environmental
stressors (Gutknecht et al., unpublished data). It has been
implicated in a wide spectrum of human behavioral traits as well
as neurodevelopmental and neuropsychiatric disorders. An
increasing body of evidence links 5-HT signaling alterations in
early development to cognitive deficits, emotional dysregulation,
and psychopathology in adult age [1,2]. During ontogeny, 5-HT
appears long before maturation of the raphe serotonergic neurons,
suggesting a fundamental role in embryonic and brain develop-
ment. Several in vitro and in vivo studies showed a morphogenetic
effect of 5-HT on proliferation, migration, differentiation,
connectivity and survival of neural cells, including the autoregu-
lation of the development of the 5-HT system itself (reviewed in
[3,4]). To further analyze the significance of brain 5-HT in general
development, the development and function of the brain and more
specifically on the differentiation and specification of the
serotonergic system itself, we have generated a mouse model
displaying a brain-specific 5-HT deficiency resulting from a
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genetically driven inactivation of neuronal tryptophan hydroxy-
lase-2 (Tph2, NCBI: protein, NP_775567.2; gene ID, 216343,
[5]). Tph2 is the key enzyme in the synthesis of neuronal 5-HT [5–
8] and catalyzes the hydroxylation of tryptophan (Trp) to 5-
hydroxytryptophan (5-HTP) which is transformed to 5-HT by the
amino acid decarboxylase (AADC). Tph2 is specifically expressed
in the 5-HT neurons of the brainstem raphe complex and is
exclusively responsible for the 5-HT synthesis within the brain [7],
while Tph1 (NCBI: NP_033440) is the peripheral isoform. Tph2
null mutant (Tph22/2) mice thus lack the ability to synthesize 5-
HT specifically in brain and as a consequence have lost the
capacity to release 5-HT and to establish serotonergic neuro-
transmission, while their peripheral 5-HT production is left intact.
Other but different models of genetically driven central 5-HT
reduction were previously generated, such as the Tph2 R439H
knockin mice [9], yet, this mutation only induces a 50% reduction
of extracellular 5-HT in brain regions [10]. Mice with inactivation
of the Pet1 [11] and Lmx1b [12,13] genes, coding for transcription
factors involved in the specification of serotonergic neurons were
also generated. However, both represent modification ‘‘upstream’’
of the specification process rather than a specific inactivation of
neuronal 5-HT synthesis. In Pet1 knockout mice (Pet1 KO), 5-HT
deficiency is incomplete with approximately 30% of the differen-
tiated 5-HT neurons remaining in various raphe nuclei [14]. In
conditional Lmx1b knockout mice (Lmx1b cKO), in which the gene
deletion is driven specifically in serotonergic neurons, 5-HT
neurons are generated but fail to differentiate and survive [15]. In
contrast, in Tph22/2 mice, serotonergic neurons and their
projections are still present but devoid of 5-HT [5].
In the present study, we investigated the impact of brain 5-HT
deficiency on general and brain development, function of other
monoamine neurotransmitters and on the specification and
maintenance of the serotonergic system itself with focus on the
neurochemical, molecular, cellular, and electrophysiological phe-
notype.
Results
Growth Retardation and Persistent Leanness in Tph22/2
but Age- and Sex-dependent Overweight in Tph2+/2
Mice
5-HT is implicated in the regulation of various physiological
pathways influencing somatic growth, appetite, energy expendi-
ture and storage. To evaluate the effect of central 5-HT deficiency
on the regulation of these mechanisms, body weight was
determined in different Tph2 mutants compared to wildtype (wt)
littermates at different ages from 3 weeks up to 2.2 years. First, as
visible in Fig. 1, adult Tph2-deficient mice display an overall
normal life expectancy. Using age as a covariable, growth
retardation and leanness which persists throughout the lifespan
was observed in Tph22/2 males (F(2,417) = 11.56, p,0.001;
Bonferroni-corrected pair-wise comparisons: 2/2 , wt and +/
2, p,0.001) and Tph22/2 females (F(2,370) = 14.624, p,0.001;
2/2 , wt, p = 0.02; 2/2 , +/2, p,0.001). During their first
24 weeks of life, Tph22/2 females had lower body weight than wt
and +/2 (F(2,264) = 11.86, p,0.001, 2/2 , wt and +/2,
p,0.001) but wt and Tph2+/2 mice did not differ (p = 0.25).
However, from 24 weeks of age onward, female +/2 mice started
to diverge from wt littermates showing an increase in their rate of
weight gain (F(2,88) = 15.95, p,0.001; wt , +/2, p = 0.031; 2/2
, wt, p = 0.013; 2/2 , +/2, p,0.001). Dissection revealed that
Tph2+/2 females can have impressive amount of fat stored in
their abdominal and pericardial cavity, particularly in advanced
age, while fat pads in Tph22/2 were much reduced compared to
their littermates. Although Tph2+/2 males also appeared to be
more obese, their body weight did not significantly differ from wt
controls before (F(2,320) = 24.713, p,0.001; wt vs +/2, p = 1; 2/2
, wt, p,0.001; 2/2 , +/2, p,0.001) or after 24 weeks of age
(F(2,79) = 15.68, p,0.001; wt vs +/2, p = 0.46; 2/2 , wt,
p,0.001; 2/2 , +/2, p,0.001). These results reveal a dual
impact of central 5-HT in the regulation of somatic development
and metabolic homeostasis and that brain 5-HT deficiency dose-
dependently affects body weight via partially opposing mecha-
nisms.
Tph2 Inactivation Results in Brain 5-HT Deficiency and
Reduction of Norepinephrine
To assess the effect of Tph2 inactivation on brain 5-HT and its
influence on the function of other neurotransmitter systems,
monoamine concentrations were first analyzed by high-perfor-
mance liquid chromatography (HPLC) in different brain regions of
phosphate buffered saline (PBS) perfused animals (Fig. 2A).
5-HT. Tph2 inactivation dramatically decreased 5-HT con-
centrations in all brain regions (H(2).15.4, p,0.001). When
compared to wt littermates, Tph22/2 mice exhibited a reduction
of 5-HT concentrations reaching 94.8% in rostral raphe (RR),
95.2% in hippocampus (Hip), 91.8% in frontal cortex (FC) and
88.6% in thalamus (T) (all p,0.001). 5-HT in Tph2+/2 mice was
reduced to a much lesser extent and the only brain region for
which the difference reached significance was the RR with a
21.8% reduction (p = 0.006) compared to wt mice.
5-hydroxyindoleacetic acid (5-HIAA). Levels of 5-HIAA,
the main 5-HT metabolite, were different across genotypes in all
regions (H(2).16.2, p,0.001). The extent of reduction in Tph22/
2 mice compared to wt was even more pronounced than for 5-HT
with 98.4% reduction in RR, 96.0% in Hip, 96.7% in FC and
94.8% in T (all p#0.001). In Tph2+/2, 5-HIAA concentrations
were significantly lower in RR (230.4%, p= 0.016), FC (232.3%,
p= 0.036) and tended to be decreased in T (215.1%, p= 0.093)
but not in Hip suggesting a region- and gene dose-dependent
compensatory reduction of 5-HT turnover.
Because brain 5-HT was extremely reduced but not completely
absent in Tph22/2 mice, we hypothesized that trace 5-HT may
derive from platelets containing high levels of 5-HT and remaining
in brain capillaries. Therefore, we carried out another 5-HT
concentration analysis in a second set of animals which underwent
a refined and more efficient perfusion protocol resulting in a more
complete removal of residual blood from the brain. This analysis
demonstrated a further reduction of 5-HT up to an additional
7.7% in Tph22/2mice. Eventually, the 5-HT reduction in Tph2-
deficient mice was 98.9% in RR, 96.2% in Hip, 94.0% in FC and
96.3% in T, strongly supporting the notion that most of the 5-HT
traces detected in Tph22/2 brain is carried by vascular perfusion
and thus of peripheral origin.
Norepinephrine (NE). 5-HT deficiency in Tph22/2 mice
was accompanied by a reduction of NE concentrations across
brain regions (H(2).9.7, p#0.008). Compared to wt controls,
Tph22/2 mice displayed significant reduction of 28.3% in RR
(p= 0.005), 38.6% in Hip (p= 0.002), 43.3% in FC (p= 0.001) and
29.5% in T (p= 0.002). No such significant effect was observed in
+/2 animals.
Dopamine (DA). Less consistent reductions were observed
for DA levels with a genotype effect solely in Hip (H(2) = 7.15,
p = 0.028) and FC (H(2) = 7.07, p= 0.029). In Hip, DA levels were
decreased in Tph22/2 compared to wt mice (271.9%, p= 0.019).
In FC, Tph22/2 mice also exhibited significantly lower
concentrations but only when compared to Tph2+/2 mice
(267.7%, p= 0.010).
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Reduced Number of Noradrenergic Neurons in Tph22/2
Mice
To assess the effect of 5-HT deficiency on development and
integrity of other neurotransmitter systems and to assess whether
the reduction in NE and DA levels is due to a decreased number of
catecholamine-specific neurons, noradrenergic and dopaminergic
neurons were identified by tyrosine hydroxylase (TH) immuno-
staining and quantified in their respective nuclei (Fig. 2B). TH
positive-cells were counted in the locus coeruleus (LC), the main
central NE cell cluster, located in the brain stem as well as in the
major dopaminergic nuclei, the substantia nigra (SN), ventral
tegmental area (VTA) and A8 which, in its caudal boundary, is
anatomically overlapping with the most rostral part of the dorsal
raphe (DR). Counting of noradrenergic neurons in the LC
revealed a significant reduction of cell densities in Tph22/2 mice
in subparts of this cluster, rather than in the structure as a whole.
Brain slices comprising anterior parts of LC exhibited a significant
genotype effect (F(2,17) = 5.23, p= 0.017) with a reduction of 33.8%
(p= 0.015) in Tph22/2 and 24.9% (p= 0.081) in Tph2+/2 mice
compared to wt littermates. The difference between +/2 and 2/
2 groups was 11.9% without reaching significance (p= 0.668). In
central LC, although Tph22/2 mice displayed a 17.5% reduction
of cell density, the genotype effect was not significant (F(2,23) = 1.63,
p = 0.219). The posterior LC did not reveal a significant genotype
Figure 1. Growth and body weight during lifespan. Different male and female mice were weighted at different ages between 3 weeks and 2.2
years (421 males: wt, n = 155; +/2, n = 173; 2/2, n = 93; and 374 females: wt, n= 147; +/2, n = 146; 2/2, n = 81). Tph22/2 of both sexes displayed a
growth retardation which persists throughout the lifespan as assessed by a constant significantly lower body weight than wt (males, p,0.001;
females, p = 0.02) and +/2 mice (males, p,0.001; females, p = 0.007). A significant sex-specific overweight was observed in Tph2+/2 females from 24
weeks of age onward (+/2 . wt, p = 0.031; +/2 .2/2, p,0.001), while +/2 males did not differ from wt. Age was used as covariable in the ANOVA
analyses followed by Bonferroni-corrected pair-wise comparisons.
doi:10.1371/journal.pone.0043157.g001
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effect (F(2,19) = 2.43, p = 0.115). In the DA cell clusters SN, VTA
and A8, no significant inter-genotypic difference was found. A
detailed analysis within each cluster in a rostro-caudal dissection
did also not show any difference. Since the volume of the cell
clusters did not differ between genotypes in any of the analyzed
structures, the cell density directly reflects the total number of TH-
positive cells. The reduced NE brain concentration elicited by
HPLC may then, at least in part, be explained by a reduction of
the number of TH-positive noradrenergic neurons in the LC as a
source of NE in terminal brain regions.
Serotonergic Molecular Phenotype of Raphe Neurons
Devoid of 5-HT is Conserved
Given the known neurotrophic role of 5-HT in brain
development, we have also investigated the effect of 5-HT
synthesis incapacity on the development and differentiation of
the serotonergic neurons themselves. Fig. 3a shows the absence of
Tph2 immunoreactivity in Tph22/2 rostral raphe nuclei. It was
also absent in other raphe nuclei and any further brain regions.
We had previously shown the absence of 5-HT and Tph1
immunoreactivity in the brain of Tph22/2 mice ([5] and [7]
respectively) by chromogenic immunohistochemistry. Here we
additionally tested the other 5-HT specific markers. The 5-HT
transporter (Sert) was normally present on the plasmatic soma
membrane (Fig. 3b) as well as along projecting serotonergic fibers,
e.g. in FC (Fig. 3c) but also in the other brain regions, such as Hip
[5]. Immunofluorescent labeling confirmed the absence of specific
5-HT immunoreactivity in the raphe neurons (Fig. 3e) and other
brain regions of Tph22/2 mice. The vesicular monoamine
transporter-2 (Vmat2), which is in the raphe nuclei specifically
expressed in wt 5-HT positive neurons (Fig. 3g), was also present in
raphe neurons of Tph22/2 mice (Fig. 3f). Furthermore, using in
situ hybridization, we demonstrated the maintained expression of
the 5-HT neuron specific transcription factor Pet1 in the raphe of
Tph22/2 mice (Fig. 3d). These results, together with 5-HT1A and
5-HT1B autoradiography in raphe (see below), demonstrate a
serotonergic-like phenotype and apparently normal cellular and
morphological differentiation of the neurons despite the absence of
Tph2 and endogenous 5-HT synthesis.
Increased 5-HT1A and 5-HT1B Receptor Density and
Stimulated [35S]GTP-c-S Binding
To evaluate the effect of 5-HT deficiency on the regulation of its
autoreceptors at the pre- and post-synaptic level, we have
quantified 5-HT1A and 5-HT1B receptors in relevant brain regions
(Fig. 4).
5-HT1A Receptors. Quantitative autoradiography using the
selective 5-HT1A receptor antagonist radioligand [
3H]WAY
100635 showed that specific labeling of 5-HT1A receptors was
increased in Tph22/2 compared to wt and Tph2+/2 mice in
most of the brain regions tested (Fig. 4A and 4B). ANOVA analysis
showed a consistent genotype effect (detailed in Table S1) except
in retrosplenial and entorhinal cortex. The most significant
increases of postsynaptic 5-HT1A heteroceptors compared to wt
mice were found in the FC and septum (Sep) (+73%; p,0.001 and
+63%; p,0.001 respectively), followed by the Hip (+19–22%;
Figure 2. Neurotransmitter concentrations and TH positive cells counting in different brain regions. (A) HPLC analysis of
norepinephrine (NE), dopamine (DA), serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in four different brain regions showed a
drastic reduction of 5-HT and 5-HIAA concentrations in the brain of Tph22/2 compared to wt and +/2 mice (n = 8). This reduction was further
increased by an improved perfusion protocol (see corresponding results section) with e.g. 98.9% reduction in rostral raphe. A general reduction of NE
concentration was also observed across brain regions of Tph22/2 mice compared to wt and +/2 and a reduction of DA concentration in the
hippocampus compared to wt mice. Kruskall-Wallis followed by Mann-Whitney-U-test: *p,0.05, **p,0.01, ***p,0.001. (B) Top: density of tyrosine
hydroxylase (TH) positive cells in the locus coeruleus (LC, main noradrenergic cell cluster in the brain) showing a reduction of cell number in the
anterior LC (aLC) of Tph22/2 mice (n = 8). Botom: density of TH positive cells in the main dopaminergic cell clusters: subtantia nigra (SN), ventral
tegmental area (VTA) and retrorubal field A8 (n = 8). cLC: central LC, pLC: posterior LC. ANOVA followed by Tuckey-HSD: *p,0.05. Data are presented
as means 6 sem.
doi:10.1371/journal.pone.0043157.g002
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0.04,p,0.001) and amygdala (A) (+15%; p,0.05). In the DR,
expressing mostly presynaptic 5-HT1A autoreceptors, the specific
labeling was also increased (+12%; p= 0.016) but to a lesser extent
than in forebrain regions. The findings from parallel experiments
using 5-carboxamidotryptamine (5-CT) to stimulate [35S]GTP-c-S
coupling were in accordance with receptor density increases and
reflected an enhanced labeling by [35S]GTP-c-S after stimulation
in Tph22/2 mice particularly in the FC (+54%, p= 0.04 compare
to +/+) and Sep (+24%, p= 0.04 compare to wt; +/2 vs wt: +23%,
p= 0.048) (Fig. 4C, Table S1). This labeling was completely
prevented by WAY 100635 showing that it may be specifically
attributed to 5-HT1A receptor stimulation. In the brain regions
where the increase in 5-HT1A density was more moderate, such as
DR, Hip and other cortical regions, the difference in [35S]GTP-c-
S coupling did not reach significance.
5-HT1B Receptors. Quantitative autoradiography with iodo-
cyanopindolol ([125I]ICYP) in presence of isoproterenol (to mask
ß-adrenergic binding sites) showed labeling exclusively in the brain
regions with high expression of 5-HT1B receptors. In Tph2 mutant
mice, a significant increase of 5-HT1B receptors labeling was
observed in the Sep (2/2 vs wt: +64%, p= 0.002; 2/2 vs +/2:
+30%, p= 0.048), FC (2/2 vs wt: +63%, p= 0.034), caudate
putamen (2/2 vs wt: +44%, p= 0.034), globus pallidus (2/2 vs
wt: +28%, p= 0.004) and lateral hypothalamus (2/2 vs wt: +39%,
p= 0.025) but not in SN, Hip or DR (Fig. 4D, Table S1).
[35S]GTP-c-S binding after stimulation did not reveal significant
genotype effect but a trend in the SN (F(2,12) = 3.32; p = 0.08),
where +/2 and2/2mice tend to have lower 5-HT1B stimulation
than wt (217% and 214%, respectively), however, between
groups comparison did not yield significant differences. Receptor
labeling was blocked by the selective 5-HT1B/1D antagonist
GR127935. These results demonstrate that, despite the absence
of 5-HT synthesis, the expression of these receptors is retained in
Tph22/2 mice, while they show generalized up-regulation as an
adaptation to the lack of endogenous ligand.
Electrophysiological Properties of Serotonergic Neurons
are Preserved in Tph22/2 Mice
Another critical feature of maturation and physiological
function of a specific neuron population is the acquisition of its
specific electrophysiological characteristics. To investigate whether
Tph2 and thus 5-HT synthesis are required for the development
and maintenance of 5-HT neuron-specific electrophysiological
activity, we studied serotonergic DR neurons and recorded their
spontaneous firing and response to various compounds in order to
verify the complete absence of Tph activity and the functionality of
autoinhibitory mechanisms (Fig. 5).
Figure 3. Histological characterization of serotonergic neu-
rons. Detection of serotonergic-specific markers was performed on
coronal brain sections of adult wt control (left panel) and Tph22/2
mice (right panel). Protein labeling was obtained by light immunohis-
tochemistry (a-c) and immunohistofluorescence (e-g). (a) Labeling of
Tph2 demonstrated its complete absence in the raphe of Tph22/2
mice. (b) The serotonin transporter (Sert) could be detected in both wt
and Tph22/2 mice, in the raphe as well as along fibers in projection
areas, e.g. in the frontal cortex (FC) as shown in (c). (d) Detection of the
serotonergic-specific transcription factor Pet1 in the raphe by in situ
hybridization occurred similarly in wt and Tph22/2 mice. (e) Detection
of serotonin (5-HT) in the raphe showed the absence of specific 5-HT
immunoreactivity in Tph22/2 mice. Cell nuclei were also labeled by
DAPI staining. (f) The vesicular monoamine transporter-2 (Vmat2) could
be detected similarly in the raphe of both wt and Tph22/2 mice. (g)
Merged images from (e-f) showed the colocalization of 5-HT and Vmat2
in the serotonergic neurons of wt (yellow in g) while Tph22/2 neurons
were only labeled with Vmat2 (red in g). Taken together these results
demonstrate that despite 5-HT synthesis deficiency, serotonergic
neurons of Tph22/2 mice can develop and be maintained. Moreover,
except Tph2 and 5-HT, they possess all known 5-HT-specific markers
showing that their serotonergic specification took place. Bars represent
100 mm in (c) and 200 mm in (a), (b), (d), (e-g).
doi:10.1371/journal.pone.0043157.g003
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Activity of 5-HT Devoid Raphe Neurons at
Baseline. Serotonergic DR neurons recorded with loose-seal
cell-attached voltage clamp in slices taken from Tph22/2 and
Tph2+/2 mice showed electrophysiological characteristics similar
to those observed in serotonergic neurons of wt mice. In the
presence of 10 mM phenylephrine, the population of serotonergic
neurons recorded from Tph22/2 (n = 21), Tph2+/2 (n = 25) and
wt (n = 19) mice showed regular firing with similar mean firing rate
Figure 4. Quantitative autoradiography of 5-HT1A and 5-HT1B receptors in various brain regions. (A) Representative photomicrographs
of autoradiograms following the binding of [3H]WAY100635 to 5-HT1A receptors on whole coronal sections. The signal was visibly increased in e.g.
the dorsal raphe, CA1 of hippocampus, frontal cortex and septum of Tph22/2 mice. (B) Binding density of 5-HT1A receptors labeled by the
radioligand [3H]WAY100635 was up-regulated in most of the brain regions of Tph22/2 mice. (C) 5-HT1A receptor-mediated increase in [
35S]GTP-c-S
binding after stimulation revealed enhanced 5-HT1A coupling in the frontal cortex and septum of Tph22/2 mice. (D) Binding density of 5-HT1B
receptors labeled by the radioligand [125I]ICYP was also increased in some brain regions of Tph22/2 mice. For (B, C, D) results are expressed as
optical density (OD= specific OD – nonspecific OD) and presented as means 6 sem (n= 5). * indicates ANOVA significant output for genotype effect
with *p,0.05, **p,0.01, ***p,0.001. For detailed statistical results see Table S1. c: cortex, Ss: somatosensory, Retrospl.: retrosplenial, CA1: cornu
ammonis area 1 of hippocampus, g: gyrus, D: dorsal, Enth.: enthorinal, Caud. put.: caudate putamen, V pal.: ventral pallidus, Globus pal.: globus
pallidus, Hypo. lat.: lateral hypothalamus, D subic.: dorsal subicullum, Subst. nigra: substantia nigra.
doi:10.1371/journal.pone.0043157.g004
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(F(2,62) = 0.7480, p = 0.4775; Fig. 5A). The up-to-downstroke
interval of the action current (proportional to action potential
half-width, Fig. 5C) was also similar across genotypes
(F(2,62) = 1.452, p= 0.2421; Fig. 5B).
In all recorded neurons from mutant and wtmice, application of
30 nM R-8-OH-DPAT (DPAT, 5-HT1A agonist) inhibited firing,
indicating typical 5-HT1A autoreceptor function (e.g. Fig. 5D).
Testing 5-HT Synthesis by a Functional Assay. In slices,
application of Trp increases de novo synthesis of 5-HT leading to
increase in extracellular 5-HT which, in turn, activates somato-
dendritic 5-HT1A receptors thereby inhibiting serotonergic neuron
activity [16–18]. To functionally test whether in Tph22/2 mice
serotonergic neurons are capable to synthesize 5-HT, we studied
the effect of the application of 30 and 100 mM Trp on the firing
rate of serotonergic neurons. As shown in Fig. 5D and E, the
superfusion of Trp decreased firing rate of serotonergic neurons
recorded in DR slices from wt and Tph2+/2 mice, but not of those
from Tph22/2 mice, confirming the absence of Tph activity and
complete loss of 5-HT synthesis capacity from Trp in these
neurons. In addition, in Tph22/2 mice, application of 5-HTP
(the Tph2 product and 5-HT precursor) reversibly silenced
serotonergic neurons (Fig. 5D), indicating that 5-HT metabolism
downstream of Tph2 and functional response of serotonergic
neurons to endogenous 5-HT, when present, are preserved in
Tph22/2 mice.
Discussion
Our results provide evidence that gene-targeted Tph2 inactiva-
tion results in 1) loss of brain 5-HT synthesis, 2) growth retardation
and persistent leanness but differential age-, sex- and dose-
dependent effects on body weight across the lifespan, 3) conserved
expression of all known serotonergic neuron-specific markers
(except Tph2 and 5-HT), 4) preserved electrophysiological
properties characteristic for 5-HT neurons, 5) up-regulation of
5-HT1A and 5-HT1B receptors across brain regions and 6) a
reduction of NE concentrations which is consistent with the
reduced number of noradrenergic neurons.
Growth Retardation and Dual Dose-dependent Body
Weight Regulation
While a normal overall life expectancy was observed for adult
Tph2-deficient mice, both male and female Tph22/2 mice
consistently displayed leanness with lower body weights than their
littermates. Hypomorphism was observed during the early
developmental period and persisted across the entire lifespan
reflecting reduced fat storage. This reduction of body weight may
result from altered regulation at different levels, including reduced
food intake, implicating impaired perception of energy needs and
satiety; increased metabolic activity and energy expenditure or
lower storage, implicating dysregulated glucose, lipid and protein
metabolic cycles or thermoregulation. Growth retardation in
another mouse line of Tph22/2 mice was previously observed but
with a catch-up starting after weaning and normal weight reached
at age 4 months [19]; however, these mice differ from ours by their
genetic background and older mice were not studied. Consistent
with our findings, other authors reported persistent low body
weight in Tph22/2 mice at 24 and 48 weeks associated with a
reduced fat pad and size and with both reduced food intake and
increased metabolism linked to altered leptin regulation [20].
The leanness of 5-HT deficient mice was unexpected in the face
of reports that 5-HT or drugs increasing its release are classically
found anorexigenic via hypothalamic actions [21], reducing meal
size and body weight [21–25] and increasing energy expenditure
[26]. While the low body weight of Tph22/2 contrasts previous
findings and conclusions, observation of obesity in Tph2+/2
(exhibiting reduced brain 5-HT) as reflected by excess abdominal
and pericardial fat storage, particularly in Tph2+/2 females
beyond 24 weeks, concurs. Similar complex dual roles of 5-HT
was suggested by studies in the nematode C. elegans [27]. In mice,
5-HT transporter null mutants (5-Htt2/2), which display
increased synaptic 5-HT but a reduced synthesis and total 5-HT
brain concentrations [28] also develop obesity in adulthood
[29,30]. In summary, the sex- and gene dose-dependent divergent
body weight and fat storage phenotypes in Tph2 mutant mice
supports the notion of a nonlinear dual effect of central 5-HT on
somatic development, long-term body weight regulation, and
metabolic homeostasis via different pathways interacting with
hormonal status.
5-HT Deficiency and Impact on other Neurotransmitter
Systems
In Tph22/2 mutants 5-HT concentrations are dramatically
reduced across brain regions and virtually absent from the
serotonergic neuron-containing raphe region with only traces
detectable by HPLC, demonstrating that 5-HT synthesis within
neurons depends on the activity of the Tph2 isoform. While
perfusion of brain with removal of most of the residual blood in
capillaries resulted in minimal amounts of 5-HT in rostral raphe
region at the lower detection limit (,1.2% in Tph22/2), it is still
likely that a few blood cells with high 5-HT content, such as
platelets or mastocytes, remain trapped in capillaries or that blood
diffused post-mortem in brain tissue. Very low brain 5-HT levels
were also detected in other Tph22/2 mice [19] as well as in
Tph1/Tph22/2 double-knockout mice [31]. In addition, we
previously showed that Tph1 is not upregulated in Tph22/2
brain indicating that Tph1-driven synthesis can be ruled out in the
brain [7]. However, there are several alternative explanations for
the remaining traces: 1) HPLC does not detect 5-HT in Tph2-
deficient mice but a closely related compound with the same
retention time, a possibility which could be resolved by mass
spectrometry, 2) minimal amount of the immediate 5-HT
precursor, 5-HTP, produced by peripheral Tph1 crosses the
blood brain barrier and can be transformed into 5-HT since
AADC is ubiquitously expressed, 3) other enzymes, such as
phenylalanine hydroxylase, or as yet unknown enzymes, use Trp
as substrate and produce a small amount of 5-HT, 4) alternative
metabolic pathways are able to produce 5-HT as end- or by-
product. Of note, 5-HIAA is more reduced, or even undetectable,
than 5-HT itself suggesting that either the metabolic pathway of 5-
HT is inhibited, with MAOA activity specifically down-regulated
in 5-HT neurons, or the 5-HT-like traces do not represent 5-HT
but another compound degraded via another pathway. Taken
together, the deficiency in 5-HT availability is so extreme that we
assume that 5-HT neurotransmission is abolished in Tph22/2
brain despite the presence of neurons with serotonergic cell-like
specification.
While DA concentrations are only reduced in Hip, 5-HT
deficiency is accompanied by a consistent reduction of NE across
brain regions. Tph22/2 mice exhibited a reduced number of TH
expressing cells in some subparts of the LC which can partly
explain the lower NE content in its projection areas. The LC is
extensively innervated by Sert-positive fibers containing 5-HT in
wt controls and devoid of 5-HT in Tph22/2 mice. We
hypothesize that the absent trophic effect of 5-HT in Tph22/2
mice impacts development or survival of NE-specific neurons.
Alternatively, absence of 5-HT release prevents the stimulation or
inhibits, presumably by indirect input from inhibitory GABAergic
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Figure 5. Electrophysiological characteristics of serotonergic raphe neurons. Tph22/2 mice displayed electrophysiological characteristics
similar to +/2 and wt mice comprising (A) mean firing rate of the recorded neurons measured over a 3 min interval; (B) Up-to-Downstroke Interval
(UDI) measured as shown in (C); wt: n = 19; Tph2+/2: n = 25; Tph22/2: n = 21. (D) Representative time-course of the effect of tryptophan (Trp 30 and
100 mM) and R-8-OH-DPAT (DPAT; 30 nM) application on the firing rate of serotonergic neurons in slices taken from wt (upper panel), Tph2+/2
(middle panel) and Tph22/2 (lower panel) mice. Lower panel also illustrates the response of Tph22/2 mice to the application of 30 mM L-5-
hydroxytryptophan (5-HTP). 5-HTP stopped the firing of serotonergic neurons in all three genotypes. (E) Bar graph summarizes the responses to Trp
application shown in (D). Both concentrations of Trp (30 and 100 mM) did not change firing of serotonergic neurons in Tph22/2, but significantly
inhibited serotonergic neuron firing in wt and Tph2+/2mice (p,0.05, Wilcoxon Signed Rank Test). When compared across genotypes, the responses
of Tph22/2 serotonergic neurons were statistically different from those of +/2 and wt mice both for Trp 30 mM (H(2) = 16.28, p,0.0003, wt n= 7;
Tph2+/2 n= 10; Tph22/2 n=12) and 100 mM (H(2) = 10.43, p = 0.0054, wt n= 7; Tph2+/2 n= 8; Tph22/2 n= 8; Kruskal-Wallis, followed by Dunn’s
multiple comparison test). Diagram bars represent means 6 SD.
doi:10.1371/journal.pone.0043157.g005
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or excitatory glutamatergic neurons, expression and activity of TH
in NE neurons. Several studies reported that chronic treatment
with the SSRI fluoxetine induces an increase of TH gene
expression in the LC [32]. Conversely, 5-HT deficiency may thus
down-regulate TH activity in the LC, eventually reducing NE
biosynthesis. TH is also present along NE fibers projecting towards
target areas and regulation at the level of terminals is likely since
the DR does not seem to exert a direct inhibitory influence on the
release of NE in the LC [33]. While 5-HT and NE fibers with
synaptic varicosities colocalize in forebrain regions, a feedback
loop involving alpha-2 adrenergic receptors on 5-HT fibers and 5-
HT3 receptors on NE fibers, allows a reciprocal regulation of
release of both neurotransmitters by which 5-HT3 receptors
stimulate the synaptic release of NE [34]. The stimulation of the
neurotransmitter release is accompanied by an activation of its
synthesis, whereas the lack of stimulating effect by 5-HT on NE
fibers dampens TH activity and thus NE synthesis. The interaction
between serotonergic and noradrenergic systems have attracted
attention as both systems are implicated in the control of a wide
range of complex behaviors as well as the pathogenesis of affective
disorders and their treatment by dual 5-HT/NE reuptake
inhibitors (SNRI) [35]. Although moderate increase of brain NE
content was observed in other Tph22/2 mice [20], the NE
concentrations reported in [19] and [31] tend to be reduced but
the difference did not reach significance. Overall, the findings
confirm that serotonergic and noradrenergic systems are interde-
pendent and subject to co-regulation involved in behavior and
psychopathology.
Molecular Specification of Raphe Neurons Lacking 5-HT
Synthesis
Although considerable evidence supports morphogenetic
properties of 5-HT [3,4] regulating proliferation, migration
and differentiation of neural cells, we did not observe gross
neuroanatomical alteration in the brain of Tph22/2 mice. One
of the aims of the present study was to elucidate whether
expression of genes specifying a serotonergic phenotype is
conserved in raphe neurons lacking 5-HT synthesis. We
demonstrated that Sert is present on the soma of raphe neurons
as well as on their fibers and terminals in the various projection
areas, although they had lost the capacity to synthesize and thus
release 5-HT (Fig. 3 and [5]). In addition to Sert, the
serotonergic cell-specific transcription factor Pet1, the monoam-
inergic-specific Vmat2 as well as 5-HT1A functioning as
somatodendritic autoreceptors, are expressed by neurons
displaying a 5-HT neuron-like morphological phenotype in
Tph22/2 mice. Finally, the 5-HT devoid neurons exhibit
typical electrophysiological properties of pacemaker firing and
are able to produce 5-HT via AADC if supplemented with 5-
HTP, suggesting a functional 5-HT synthesis pathway down-
stream Tph2. While the genetic inactivation of the upstream
transcription factors Lmx1b and Pet1 compromises the devel-
opment of the majority of 5-HT neurons [11–13], we conclude
that intrinsic 5-HT production is neither essential for the
development, differenciation, maintenance and survival of
serotonergic neurons, nor for the molecular specification of a
serotonergic-like phenotype. It remains, however, to be eluci-
dated in detail whether subtle alteration in dendritic arboriza-
tion, neurite target finding, or brain structures innervation
occurs and whether serotonergic neurons use neuropeptides
and/or other monoamines with low affinity for the Sert as
physiological or ‘‘borrowed’’ neuromodulator or transmitter in
establishing function and connectivity.
Adaptive 5-HT1A and 5-HT1B Receptors Regulation
The density of 5-HT1A and 5-HT1B receptors and their G-
protein coupling were significantly increased across many brain
regions of 5-HT deficient Tph22/2 male mice, particularly in
terminal fields of the FC and Sep. These findings are in
accordance with an early study showing that complete abolition
of 5-HT synthesis by p-chlorophenylalanine (PCPA) treatment led
to significant up-regulation of 5-HT1A and 5-HT1B receptor
binding sites evaluated in cerebral cortex areas [36]. The opposite
phenomenon was observed in mouse models characterized by
robust increases of extracellular 5-HT in the brain such as MAO-
A null mutant mice where 5-HT1A and 5-HT1B receptors are
desensitized and down-regulated [37,38] and, to a lesser extent
and in a brain region specific manner, in 5-Htt2/2 mice [39,40].
Interestingly, 5-HT1A receptors are down-regulated in patients
with depression and anxiety disorders as well as during SSRI
treatment [41–43]. Sensitization and up-regulation of 5-HT1A and
5-HT1B receptors in 5-HT deficient mice may likely be due to
direct cellular and molecular mechanisms compensating for
reduced 5-HT ligand availability by an increase of Htr1a and
Htr1b gene expression in target neurons, resulting in increased
receptors production and thus increased binding site densities.
5-HT Deficient Neurons Retain their Electrophysiological
Properties
In Tph22/2 mice, serotonergic raphe neurons appear mor-
phologically conserved and express all known markers of
serotonergic specification (except Tph2 and 5-HT). In brainstem
slices obtained from Tph22/2 mice, serotonergic neurons also
retained the typical slow (1–2 spikes/s) tonic firing pattern which,
together with the preserved shape of the action current, indicates
that this spontaneous firing is independent from endogenous 5-HT
synthesis and moreover that the absence of 5-HT did not produce
adaptive changes of voltage-sensitive membrane channels respon-
sible for the pacemaker activity. Relevant to the functional
effectiveness of Tph2 gene deletion, the fact that Trp did not
inhibit the firing of serotonergic neurons clearly shows that
synthesis of neuronal 5-HT is mediated exclusively by the Tph2
isoform and that it is abolished in the neurons of Tph22/2 mice.
However, when in slices from Tph22/2 mice, the Tph2-
dependent step of 5-HT synthesis is bypassed by supplementation
with intermediary 5-HTP (that is converted into 5-HT by AADC)
a robust 5-HT1A autoreceptor-mediated inhibition of neuron
firing is revealed, showing that responsiveness of serotonergic
neurons to 5-HT persists in Tph22/2 neurons. This finding,
together with the preserved response to the selective 5-HT1A
agonist DPAT, shows that 5-HT1A receptors are functional and
confirms that the lack of response of serotonergic neurons to Trp
in Tph22/2 mice is indeed due to the lack of Tph2 and not to the
absence of functional 5-HT1A-mediated autoinhibition or their
downstream effectors. In brainstem slices from Tph2+/2 mice,
serotonergic neurons responded to Trp application with a decrease
in firing rate that was similar to that observed in wt mice, showing
that gene dose dependent reduction of 5-HT synthesis does not
result in functional changes in the 5-HT system at baseline.
Overall, electrophysiological data provide evidence that endoge-
nous 5-HT is not required for acquisition and preservation of the
functional properties typical of serotonergic neurons.
Conclusion and Perspectives
This study examined the consequence of brain 5-HT deficiency
from the earliest stage of ontogeny on somatic growth, brain
development and the differentiation of the serotonergic system
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itself at various levels. First, we found that brain 5-HT has a dose-
dependent dual nonlinear effect on the regulation of body weight
probably involving distinct mechanisms interacting with hormonal
system. Although, in vitro and in vivo previous studies, using
neurotoxins, SSRIs or genetically driven 5-HT alterations
[3,4,44], indicated a morphogenetic developmental role for 5-
HT during brain development, Tph22/2 mice are viable and
their brain appears structurally normal except a moderate
reduction of NE neurons number. Since the mice investigated
here were all born to Tph2+/2 mothers with limited 5-HT loss in
the brain (and normal level in the periphery), and the placenta is
able to produce 5-HT (e.g. [45]), it is possible that Tph22/2
embryos’ brain received during early prenatal development and
until their blood brain barrier (BBB) is closed, sufficient 5-HT of
exogenous origin (peripheral, placental or maternal) to pursue
virtually normal prenatal development, however, a complete
compensation is still unlikely. The critical developmental window
during which 5-HT signaling deficiency have deleterious effects on
brain development is thus in the early phase of development and is
independent of endogenous neuronal 5-HT synthesis. Given that
Tph2, but nether Tph1, is expressed in the mouse brain from
embryonic day (E) 10–10.5 [7,46], the critical period might be
likely before E10, however, a role for exogenous 5-HT is still
possible until the BBB is closed. This underlines that, if 5-HT is
necessary for normal brain development, exogenous 5-HT, most
likely Tph1-derived and of maternal, placental and/or peripheral
origin, is the critical source for early prenatal brain development
[46]. Alternatively, it seems that, except for the use of neurotoxins
which might have other 5-HT-independent toxic side-effects, an
excess of 5-HT signaling (in 5-Htt2/2 or SSRI treatments) has
more deleterious effects on brain development than 5-HT
deficiency. Nevertheless, in adult age, 5-HT synthesis deficiency
results in behavioral alterations including in response to environ-
mental stressors (Gutknecht et al., unpublished data), reduces the
function of other monoaminergic systems and may also have an
impact on brain repair in case of injury. Our results also
demonstrate that the proper cellular and molecular differentiation
and the maintenance of the serotonergic neuron phenotype do not
require endogenous 5-HT synthesis. Moreover, serotonergic
neurons continue to display characteristic spontaneous firing
although they are devoid of 5-HT showing that this electrophys-
iological mechanism depends on programming independent from
5-HT synthesis and release. Finally, it remains to be determined
whether serotonergic neurons play a physiologically relevant role
independent from 5-HT neurotransmission and via which
pathway(s). Such supplementary signaling would equip serotoner-
gic neurons with an as yet unknown parallel function.
Materials and Methods
Animals and Ethics Statement
All animal manipulations were approved by the review board of
the government of lower Franconia and the University of
Wuerzburg, and performed according to the European Commu-
nity guidelines for animal care (Permit number: DL 116/92,
application of the European Communities Council Directive 86/
609/EEC). A maximum effort was made to minimize the number
of animals used and their suffering - see also Supporting
Information (SI) (Text S1, Supplemental Materials and Methods).
The generation and genotyping procedure of Tph22/2 animals
have been described in [5]. Their genetic background is composed
theoretically of 97% C57BL/6N and 3% Sv129/Ola.
Body Weight Across the Lifespan
Body weight was determined in different animals at different
ages from 3 weeks up to 2.2 years. The weighted cohort included
421 males: 155 wt, 173+/2 and 932/2 and 374 females: 147 wt,
146+/2 and 812/2. Age was used as covariable in the ANOVA
comparison between genotypes within each sex.
Brain Neurotransmitters Concentrations
Two independent cohorts of 4 months old mice were used. The
first one was composed of 8 Tph22/2 (mixed 4 males and 4
females because of the low number of 2/2 animals at that time),
8+/2 males and 8 wt males which were perfused for 10 min with
PBS. Since no sex effect could be observed, Tph22/2 mice were
subsequently pooled in the graphs and analyses. ANOVA
requirements failed in a majority of cases, therefore, we applied
to all non-parametric analysis of variance. Because the efficiency of
the brain perfusion was not ideal and blood traces were still visible
in the brain of the first animals, a second cohort composed
exclusively of males with 4 Tph22/2, 4+/2 and 4 wt, was used to
reanalyze 5-HT concentrations in brain regions. These animals
were this time perfused for 10 min at higher pump debit with PBS
containing 20 U/ml Heparin. Perfusion was obviously better and
brains were visibly whiter. For both cohorts, brains were
immediately frozen until brain regions were dissected and
neurotransmitters concentrations analysed using HPLC as de-
scribed in SI (Text S1).
Histological Staining
Immunohistochemical stainings were performed on brains fixed
by perfusion with 4% paraformaldehyde, cryoprotected, frozen
and sliced into 14 mm sections. After epitope retrieval and
blocking, the primary antibodies against Tph2, Sert and TH
were applied, followed by incubation with biotinylated secondary
antibodies. Staining was revealed using the Avidin-Biotin Complex
method with diaminobenzidine as chromogene. Double-fluores-
cent 5-HT and Vmat2 primary antibodies immunostaining were
realized by applying fluorescent Alexa fluor 488- and Dylight-
conjugated secondary antibodies respectively. For Pet-1 in situ
hybridization, 16 mm sections from native frozen brains were used.
Digoxigenin (DIG) labeled Pet-1 cRNA probes were applied to
brain sections and visualized by alkaline phosphatase conjugated
anti-DIG antibody. The number of TH-immunoreactive cells was
quantified from 8 mice of each genotype. Detailed protocols are
described in SI (Text S1).
Receptors Binding and Stimulation
A cohort of n = 5 males per genotype, 5 months old, were used.
Frozen brains were entirely sectioned at 16 mm and spread in 8
adjacent sections series for 5-HT1A and 5-HT1B receptors specific
binding and stimulation experiments, as well as the respective non-
specific controls.
Specific binding to 5-HT1A was performed with 2 nM [
3H]-
WAY100635 and with 12 pM [125I]-Cyanopindolol for 5-HT1B.
For both receptors, nonspecific binding was estimated from
adjacent sections incubated in the same medium supplemented
with 10 mM 5-HT. Results are expressed as specific binding OD -
nonspecific OD. Agonist-stimulated binding of 0.05 nM [35S]-
GTP-c-S was performed with 1027 M 5-CT. Nonspecific binding
was determined from adjacent sections in presence of 1 nM of
antagonist WAY100635 for 5-HT1A or GR127935 for 5-HT1B.
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Electrophysiological Recording of Raphe Neurons
Mice (28 to 80 days old) were anaesthetized with isofluorane
and decapitated. The brain was rapidly removed, dissected in ice-
cold gassed (95% O2 and 5% CO2) artificial cerebrospinal fluid
(ACSF) containing (in mM): 124 NaCl, 2.75 KCl, 1.25 NaH2PO4,
1.3 MgCl2, 2 CaCl2, 26 NaHCO3, 11 D-glucose (pH 7.4), and the
brainstem was sliced coronally into 200 mm thick slices with a
vibratome. After recovery, the slices were individually transferred
into the recording chamber and superfused continuously with
warmed ACSF (34–35uC) at a rate of 2 ml min21. Neurons were
visualized by infrared differential interference contrast video
microscopy with a Newicon C2400-07 camera (Hamamatsu,
Hamamatsu City, Japan) mounted to an Axioskop microscope
(Zeiss, Go¨ttingen, Germany). Recordings were made using an
EPC-10 amplifier (HEKA Elektronic, Lamberecht, Germany).
Patch pipettes were prepared from thick-walled borosilicate glass
on a P-97 Brown-Flaming electrode puller (Sutter Instruments,
Novato, CA) and had resistance of 3–6 MV when filled with
solution containing (in mM): 125 NaCl, 10 HEPES, 2.75 KCl,
2 CaCl2, 1.3 MgCl2 (pH 7.4 with NaOH). Loose-seal cell-
attached recordings (5–20 MV seal resistance) were acquired
continuously in voltage-clamp mode. Signals were filtered at
3 kHz and digitized at 10 kHz. Pipette potential was maintained
at 0 mV. Recordings were aborted if firing rate was sensitive to
changes in pipette holding potential or if shape of action current
changed. Data were analyzed using Clampfit 9.2 (Molecular
Devices) and Prism 5 (GraphPad Software, San Diego, CA).
Extracellular saline was supplemented with 10 mM phenylephrine
to facilitate firing. Neurons were presumed serotonergic when 1)
displayed firing rate of less than 3.5 Hz, 2) had asymmetric action
current with peak-to-peak interval greater than 1 ms, and 3) their
firing stopped in response to application of the 5-HT1A receptor
agonist DPAT (30 nM) at the end of experiment. Since
experiments depended on endogenous 5-HT, recordings were
done from neurons located at least 50 mm below the slice surface
[18]. One experiment was done in each slice. The number of used
mice and recorded cells for each particular design is indicated in
results section and Fig. 5 legend.
Statistical Analysis
Unless otherwise specified, such as for electrophysiological data
analysis (see Figure legend), the effects of genotype and sex were
analyzed using ANOVA (indicated by F(df1,df2) values) followed up
with Tuckey-HSD post hoc tests for multiple group comparison.
When requirements for one-way ANOVA (normal distribution,
equality of variances) were not fulfilled, non-parametric Kruskall-
Wallis analysis of variance was applied (indicated by H(df) values),
followed by Mann-Whitney-U-Test. P,0.05 was considered
statistically significant and 0.05,p#0.10 was considered as a
trend of significance.
Supporting Information
Table S1 Detailed statistical results of the genotype
effect in the analysis of variance and post hoc tests for 5-
HT1A and 5-HT1B receptor binding densities and 5-HT1A
GTP-c-S coupling in various brain regions, n=5 males.
nd: non-determined, ns: non-significant.
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